Incidence, characteristics, and clinical impact of serious adverse events in patients with breast cancer receiving antineoplastic treatment in the ambulatory setting
Zahieh AbuAloush, Wedad Awad, Ola Mashni, Farah Shkakhwa, Ayman Al‐Faris, Maryam Al‐Omari, Sara Nabulsi, Lama Nazer · 2024
Read Incidence, characteristics, and clinical impact of serious adverse events in patients with breast cancer receiving antineoplastic treatment in the ambulatory setting by Zahieh AbuAloush, Wedad Awad, Ola Mashni, Farah Shkakhwa, Ayman Al‐Faris, Maryam Al‐Omari, Sara Nabulsi, Lama Nazer (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11518886.txt.
Description
Zahieh AbuAloush and co-authors tracked serious side effects in breast cancer patients treated with anticancer drugs in outpatient clinics, in a 2024 study. Over four months, they watched patients at infusion clinics and logged any event serious enough to send someone to emergency care, add support drugs, or change the treatment plan.
In that window, 1,168 patients received 2,547 treatment cycles. About 40 percent of patients had at least one serious event, and a quarter of cycles were touched by one. The 757 events are catalogued by type and by the regimens involved. The authors weigh the burden these events place on patients and on the clinics that must respond.
Catalog record
| CREATOR | Zahieh AbuAloush, Wedad Awad, Ola Mashni, Farah Shkakhwa, Ayman Al‐Faris, Maryam Al‐Omari, Sara Nabulsi, Lama Nazer |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |